Hubei Biocause Heilen Pharmaceutical Co., Ltd. (301211.SZ) SHZ

14.10

-0.26(-1.81%)

Updated at December 05 03:04PM

Currency In CNY

Valuation

Market Cap4.22B
Enterprise Value3.7B
P/E Ratio155.8
PEG Ratio-23.37
Price/Sales Ratio9.43
Price/Book Ratio2.61
Enterprise/Revenue8.18
Enterprise/EBITDA74.57

Fiscal Year

Fiscal YearDecember 31, 2024
Most Recent QuarterSeptember 30, 2025

Profitability

Profit Margin0.09
Operating Margin0.07

Management Effectiveness

Return On Assets0.02
Return On Equity0.02

Income Statement

Revenue445.86M
Revenue/Share1.03
Gross Profit128.59M
EBITDA126.16M
Net Income91.55M
Diluted EPS0.32

Balance Sheet

Total Cash1.57B
Total Cash/Share3.76
Total Debt3.1M
Total Debt/Equity0
Current Ratio13.95
Book Value Per Share5.41

Price History

52-Week Change3.22
52-Week High17.14
52-Week Low9.38
Moving Average 50 Days13.58
Moving Average 200 Days12.6

Statistics

Average Volume15.08M
Shares Outstanding288M
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate0.17
Trailing Annual Dividend Yield1.22
Payout Ratio1.9
Last Split Factor29:20
Last Split DateAugust 27, 2025